Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Gliadin antibodies in older population and neurological and psychiatric disorders.

Ruuskanen A, Kaukinen K, Collin P, Krekelä I, Patrikainen H, Tillonen J, Nyrke T, Laurila K, Haimila K, Partanen J, Valve R, Mäki M, Luostarinen L.

Acta Neurol Scand. 2013 Jan;127(1):19-25. doi: 10.1111/j.1600-0404.2012.01668.x. Epub 2012 Apr 12.

PMID:
22494246
2.

Clinical benefit of gluten-free diet in screen-detected older celiac disease patients.

Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R, Luostarinen M, Laurila K, Mäki M, Collin P.

BMC Gastroenterol. 2011 Dec 16;11:136. doi: 10.1186/1471-230X-11-136.

3.

Register-based data indicated nonparticipation bias in a health study among aging people.

Nummela O, Sulander T, Helakorpi S, Haapola I, Uutela A, Heinonen H, Valve R, Fogelholm M.

J Clin Epidemiol. 2011 Dec;64(12):1418-25. doi: 10.1016/j.jclinepi.2011.04.003. Epub 2011 Jul 20.

PMID:
21764556
4.

Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.

Ruuskanen A, Luostarinen L, Collin P, Krekelä I, Patrikainen H, Tillonen J, Laurila K, Haimila K, Partanen J, Mäki M, Valve R, Kaukinen K.

Dig Liver Dis. 2011 Oct;43(10):772-8. doi: 10.1016/j.dld.2011.04.025. Epub 2011 Jun 8.

PMID:
21641886
5.

Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?

Ruuskanen A, Kaukinen K, Collin P, Huhtala H, Valve R, Mäki M, Luostarinen L.

Scand J Gastroenterol. 2010 Oct;45(10):1197-202. doi: 10.3109/00365521.2010.496491.

PMID:
20545470
6.

Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study.

Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R, Mäki M, Collin P.

BMC Gastroenterol. 2009 Jun 29;9:49. doi: 10.1186/1471-230X-9-49.

7.

Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial.

Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, Fogelholm M, Talja M, Uutela A.

Diabetes Care. 2009 Aug;32(8):1418-20. doi: 10.2337/dc09-0039. Epub 2009 Apr 28.

8.

Undetected coeliac disease in the elderly: a biopsy-proven population-based study.

Vilppula A, Collin P, Mäki M, Valve R, Luostarinen M, Krekelä I, Patrikainen H, Kaukinen K, Luostarinen L.

Dig Liver Dis. 2008 Oct;40(10):809-13. doi: 10.1016/j.dld.2008.03.013. Epub 2008 May 7.

PMID:
18467196
9.

Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples.

Kronholm E, Partonen T, Laatikainen T, Peltonen M, Härmä M, Hublin C, Kaprio J, Aro AR, Partinen M, Fogelholm M, Valve R, Vahtera J, Oksanen T, Kivimäki M, Koskenvuo M, Sutela H.

J Sleep Res. 2008 Mar;17(1):54-62. doi: 10.1111/j.1365-2869.2008.00627.x. Review.

10.

Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.

Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, Ilvesmäki V, Talja M, Uutela A.

Diabetes Care. 2007 Oct;30(10):2465-70. Epub 2007 Jun 22.

PMID:
17586741
11.

Rural-urban differences in health and health behaviour: a baseline description of a community health-promotion programme for the elderly.

Fogelholm M, Valve R, Absetz P, Heinonen H, Uutela A, Patja K, Karisto A, Konttinen R, Mäkelä T, Nissinen A, Jallinoja P, Nummela O, Talja M.

Scand J Public Health. 2006;34(6):632-40.

PMID:
17132597
12.

Health psychological theory in promoting population health in Päijät-Häme, Finland: first steps toward a type 2 diabetes prevention study.

Uutela A, Absetz P, Nissinen A, Valve R, Talja M, Fogelholm M.

J Health Psychol. 2004 Jan;9(1):73-84.

PMID:
14683570
13.

The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.

Schwab US, Agren JJ, Valve R, Hallikainen MA, Sarkkinen ES, Jauhiainen M, Karvonen MK, Pesonen U, Koulu M, Uusitupa MI, Savolainen MJ.

Eur J Clin Nutr. 2002 Feb;56(2):149-56.

14.

The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.

Pihlajamäki J, Valve R, Karjalainen L, Karhapää P, Vauhkonen I, Laakso M.

Eur J Clin Invest. 2001 Apr;31(4):302-8.

PMID:
11298776
15.

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.

Karhunen L, Franssila-Kallunki A, Rissanen P, Valve R, Kolehmainen M, Rissanen A, Uusitupa M.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1567-72.

PMID:
11126207
17.

Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.

Niskanen L, Voutilainen-Kaunisto R, Teräsvirta M, Karvonen MK, Valve R, Pesonen U, Laakso M, Uusitupa MI, Koulu M.

Exp Clin Endocrinol Diabetes. 2000;108(3):235-6.

PMID:
10926322
18.
19.

Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.

Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M, Rauramaa R, Töyry J, Laakso M, Uusitupa MI.

J Clin Endocrinol Metab. 2000 Jun;85(6):2266-9.

PMID:
10852461
20.

The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E.

Helisalmi S, Valve R, Karvonen MK, Hiltunen M, Pirskanen M, Mannermaa A, Koulu M, Pesonen U, Uusitupa M, Soininen H.

Neurosci Lett. 2000 Jun 16;287(1):25-8.

PMID:
10841982
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk